Latest filing published 10 Jan 2022 for Windtree Therapeutics INC, €1.7M.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Center Laboratories, Inc.: trading record in brief
All filings by Center Laboratories, Inc. on record concern Windtree Therapeutics Inc. In total, 3 filings cover trades dated from 20 May 2020 to 30 December 2021.
The open-market record is one-sided, with 2 purchases worth €2.1M and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2022 alone, the filings show 2 purchases and no sales.
On 10 January 2022 came the latest disclosure, an open-market purchase for €1.7M in Windtree Therapeutics Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Center Laboratories, Inc.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,239,088 shares@ US$1.60Common StockSEC:0001213900-22-001391:2Canonical exit: 30 Mar 2022 (T+90)
- 55,172 shares@ US$7.25Common StockSEC:0001213900-22-001391:1Canonical exit: 18 Aug 2020 (T+90)
- 3,551,750 shares0Common StockSEC:0001213900-22-001391:0
3 of 3 declarations